Hemophilia risk factors: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:
The most potent risk factor in the development of hemophilia is the family history of hemophilia. Other risk factors include male sex and malignancies.
The most potent risk factor in the development of hemophilia is the family history of hemophilia. Other risk factors include male sex and malignancies.


==Risk Factors of Hemophilia A and B==
==Risk Factors==
Risk factors for hemophilia A and B include
*The most potent risk factor in the development of hemophilia is the family history of hemophilia.<ref name="pmid11396445">{{cite journal |vauthors=Mannucci PM, Tuddenham EG |title=The hemophilias--from royal genes to gene therapy |journal=N. Engl. J. Med. |volume=344 |issue=23 |pages=1773–9 |date=June 2001 |pmid=11396445 |doi=10.1056/NEJM200106073442307 |url=}}</ref><ref name="Ingram1976">{{cite journal|last1=Ingram|first1=G I|title=The history of haemophilia.|journal=Journal of Clinical Pathology|volume=29|issue=6|year=1976|pages=469–479|issn=0021-9746|doi=10.1136/jcp.29.6.469}}</ref>
*Family history of bleeding
*Male sex is also a very common risk factor.<ref name="pmid24533955">{{cite journal |vauthors=Di Michele DM, Gibb C, Lefkowitz JM, Ni Q, Gerber LM, Ganguly A |title=Severe and moderate haemophilia A and B in US females |journal=Haemophilia |volume=20 |issue=2 |pages=e136–43 |date=March 2014 |pmid=24533955 |doi=10.1111/hae.12364 |url=}}</ref>
*Male gender<ref>{{Cite web | title =NIH Hemophilia risk factors| url =https://www.nlm.nih.gov/medlineplus/ency/article/000538.htm }}</ref>
*Current history of malignancy can also be considered a risk factor on account of the association between malignancies and acquired hemophilia.<ref name="pmid28960809">{{cite journal |vauthors=Napolitano M, Siragusa S, Mancuso S, Kessler CM |title=Acquired haemophilia in cancer: A systematic and critical literature review |journal=Haemophilia |volume=24 |issue=1 |pages=43–56 |date=January 2018 |pmid=28960809 |doi=10.1111/hae.13355 |url=}}</ref>


==References==
==References==

Revision as of 03:15, 13 January 2019

Hemophilia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophilia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophilia risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophilia risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophilia risk factors

CDC on Hemophilia risk factors

Hemophilia risk factors in the news

Blogs on Hemophilia risk factors

Directions to Hospitals Treating Hemophilia

Risk calculators and risk factors for Hemophilia risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

The most potent risk factor in the development of hemophilia is the family history of hemophilia. Other risk factors include male sex and malignancies.

Risk Factors

  • The most potent risk factor in the development of hemophilia is the family history of hemophilia.[1][2]
  • Male sex is also a very common risk factor.[3]
  • Current history of malignancy can also be considered a risk factor on account of the association between malignancies and acquired hemophilia.[4]

References

  1. Mannucci PM, Tuddenham EG (June 2001). "The hemophilias--from royal genes to gene therapy". N. Engl. J. Med. 344 (23): 1773–9. doi:10.1056/NEJM200106073442307. PMID 11396445.
  2. Ingram, G I (1976). "The history of haemophilia". Journal of Clinical Pathology. 29 (6): 469–479. doi:10.1136/jcp.29.6.469. ISSN 0021-9746.
  3. Di Michele DM, Gibb C, Lefkowitz JM, Ni Q, Gerber LM, Ganguly A (March 2014). "Severe and moderate haemophilia A and B in US females". Haemophilia. 20 (2): e136–43. doi:10.1111/hae.12364. PMID 24533955.
  4. Napolitano M, Siragusa S, Mancuso S, Kessler CM (January 2018). "Acquired haemophilia in cancer: A systematic and critical literature review". Haemophilia. 24 (1): 43–56. doi:10.1111/hae.13355. PMID 28960809.

Template:WH Template:WS